Go <> No-Go
in Early Life Science Investments
• Venture-caliber diligence before the Close
• Arms-length or fiduciary monitoring after the Close
• Special situations
See recent diligence notes and presentations on capital risk on both sides of the table.
Inquiries regarding advisory availability may be directed to jyounger@argopond.com.
Global Institutional Engagement
A ten-year portfolio of strategic counsel, enterprise governance, and capital diligence.
North America
- Corporate and Private Capital
Akadeum Life Sciences | New View Surgical | Immune Functional Diagnostics | Silverstein Properties | Life Sciences Greenhouse Investments | IAG Capital Partners | 1315 Capital - Federal and Public Policy
United States House Committee on Small Business (Testimony) | National Institutes of Health | National Science Foundation - Health Systems and Academia
University of Michigan | University of Minnesota | University of Pennsylvania | Drexel University | Children’s Hospital of Philadelphia | Monroe Carell Jr. Children’s Hospital at Vanderbilt
Europe
- Corporate and Private Capital
Cilcare Therapeutics
Asia
- Health Systems and Academia
Duke National University of Singapore